BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
Show more...
FAQ
BioRestorative Therapies 今天的股價是多少?▼
BRTX 目前價格為 $0.14 USD,過去 24 小時上漲了 +0.84%。在圖表上更密切關注 BioRestorative Therapies 股價表現。
BioRestorative Therapies 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,BioRestorative Therapies 的股票以代號 BRTX 進行交易。
BioRestorative Therapies 的股價在上漲嗎?▼
BRTX 股票較上週下跌 -27.27%,本月下跌 -31.05%,過去一年 BioRestorative Therapies 下跌 -91.12%。
BioRestorative Therapies 的市值是多少?▼
今天 BioRestorative Therapies 的市值為 3.69M
BioRestorative Therapies 下一次財報日期是什麼時候?▼
BioRestorative Therapies 將於 November 18, 2026 公布下一次財報。
BioRestorative Therapies 去年的營收是多少?▼
BioRestorative Therapies 去年的營收為 360,000USD。
BioRestorative Therapies 去年的淨利是多少?▼
BRTX 去年的淨收益為 -14.24MUSD。
BioRestorative Therapies 有多少名員工?▼
截至 September 04, 2026,公司共有 14 名員工。
BioRestorative Therapies 位於哪個產業?▼
BioRestorative Therapies從事於Health & Wellness產業。
BioRestorative Therapies 何時完成拆股?▼
BioRestorative Therapies 上次拆股發生於 October 27, 2021,比例為 1:4000。
BioRestorative Therapies 的總部在哪裡?▼
BioRestorative Therapies 的總部位於 美國 的 MELVILLE。